Combining anti-PD-(L)1 antibodies with hyaluronidase enhances tumor growth inhibition by remodeling the stroma and improving drug delivery in pancreatic cancer models.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.